Sugi Predict

Sugi Predict / Compounds / SCHEMBL5779840

SCHEMBL5779840

SCHEMBL5779840

COc1ccc(B2OC(C)(C)C(C)(C)O2)c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.49
▸ EP300 Q09472 1/20 0.47
▸ KAT8 Q9H7Z6 1/20 0.47
▸ IMPDH2 P12268 1/20 0.41
▸ IMPDH1 P20839 1/20 0.41
▸ NQO1 P15559 1/20 0.39
▸ LPL P06858 2/20 0.39
▸ LIPG Q9Y5X9 2/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ EGFR P00533 1/20 0.37
▸ PLK1 P53350 1/20 0.37
▸ MAPT P10636 3/20 0.37
▸ HPGDS O60760 1/20 0.36
▸ CDC25B P30305 2/20 0.36
▸ SLC2A1 P11166 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CSF1R P07333 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5784094 0.90 IDO1 (0.41) IDO1EP300KAT8IMPDH2IMPDH1
SCHEMBL2027186 0.86 LPL (0.48) LPLLIPGCA1CA2CA9
SCHEMBL17071924 0.83 KMT2A (0.40) IDO1EP300KAT8EGFRMAPT
SCHEMBL16382816 0.82 LPL (0.36) IDO1EP300KAT8LPLLIPG
SCHEMBL15537194 0.81 LIPE (0.37) IDO1LPLLIPG
SCHEMBL18194212 0.80 LPL (0.44) LPLLIPGCA1CA2CA9
SCHEMBL16553033 0.80 LPL (0.44) LPLLIPGCA1CA2CA9
SCHEMBL14261558 0.80 IDO1 (0.45) IDO1EP300KAT8IMPDH2IMPDH1
SCHEMBL31314671 0.79 DGAT1 (0.44) LPLLIPGNPC1EGFRMAPT
SCHEMBL18532700 0.79 ELANE (0.41) LPLLIPGNPC1EGFRCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110343084-A Double condensed ring photochromic compound of naphtho-pyrans and preparation method thereof 天津孚信阳光科技有限公司 2019-10-18 — — CN claimed
EP-1127060-B8 HYDROBORONATION PROCESS COMMW SCIENT IND RES ORG (AU) 2005-01-05 — — EP claimed
US-20040133028-A1 Hydroboronation process COMMONWEALTH SCIENTIFIC 2004-07-08 — — US claimed
US-6680401-B1 BORON COMPOUNDS SUCH AS 4-(METHOXYMETHYL)-1,3,2-DIOXABOROLANE, USED AS COUPLERS OR CHEMICAL INTERMEDIATES FOR DRUGS, PESTICIDES OR IN COMBINATORIAL CHEMISTRY COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2004-01-20 — — US claimed
EP-1127060-A4 HYDROBORONATION PROCESS COMMW SCIENT IND RES ORG (AU) 2002-08-21 — — EP claimed
EP-1127060-A1 HYDROBORONATION PROCESS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2001-08-29 — — EP claimed
WO-2000027853-A1 HYDROBORONATION PROCESS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2000-05-18 — — WO claimed
CN-110343084-B Double-condensed ring naphthopyran photochromic compound and preparation method thereof 天津孚信阳光科技有限公司 2022-12-02 — — CN disclosed
CN-110357832-B Preparation method of aromatic amine compound, EphB4 kinase inhibitor and derivatives thereof 武汉大学 2022-03-15 — — CN disclosed
CN-110343084-A Double condensed ring photochromic compound of naphtho-pyrans and preparation method thereof 天津孚信阳光科技有限公司 2019-10-18 — — CN disclosed
CN-110343084-A Double condensed ring photochromic compound of naphtho-pyrans and preparation method thereof 天津孚信阳光科技有限公司 2019-10-18 — — CN disclosed
US-20170233409-A1 TYPE IV SECRETION SYSTEM INHIBITORS Hadjifrangiskou Maria (US) 2017-08-17 — — US disclosed
US-20170233409-A1 TYPE IV SECRETION SYSTEM INHIBITORS Hadjifrangiskou Maria (US) 2017-08-17 — — US disclosed
EP-1127060-B1 HYDROBORONATION PROCESS COMMW SCIENT IND RES ORG (AU) 2004-04-07 — — EP disclosed
US-6680401-B1 BORON COMPOUNDS SUCH AS 4-(METHOXYMETHYL)-1,3,2-DIOXABOROLANE, USED AS COUPLERS OR CHEMICAL INTERMEDIATES FOR DRUGS, PESTICIDES OR IN COMBINATORIAL CHEMISTRY COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2004-01-20 — — US disclosed
US-20030229096-A1 Substituted imidazol-pyridazine derivatives EVOTEC INTERNATIONAL GMBH (DE) 2003-12-11 — — US disclosed
WO-2003097637-A1 (IMIDAZOL-1-YL-METHYL)-PYRIDAZINE AS NMDA RECEPTOR BLOCKER F. HOFFMANN-LA ROCHE AG (CH) 2003-11-27 — — WO disclosed
EP-1127060-A4 HYDROBORONATION PROCESS COMMW SCIENT IND RES ORG (AU) 2002-08-21 — — EP disclosed
EP-1127060-A1 HYDROBORONATION PROCESS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2001-08-29 — — EP disclosed
WO-2000027853-A1 HYDROBORONATION PROCESS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2000-05-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133028-A1 Hydroboronation process ALKBH3, HPD, HVCN1 IDO1 342/4885EP300 2228/4885KAT8 1076/4885
US-20170233409-A1 TYPE IV SECRETION SYSTEM INHIBITORS NSF, TFPI, VPS4B IDO1 3835/4885EP300 1568/4885KAT8 2300/4885
US-20030229096-A1 Substituted imidazol-pyridazine derivatives GRIN2B, GRIN2A, GRIN2C IDO1 1496/4885EP300 1017/4885KAT8 2205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.